AI Science Tracker
EN

Department of Cardiology

2 discoveries from 2026

Discoveries

Machine learning for prediction of newly diagnosed atrial fibrillation after emergency percutaneous coronary intervention during hospitalization in patients with acute ST-segment elevation myocardial infarction: a multi-center prospective study.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: A multicentre prospective model predicted new atrial fibrillation after emergency PCI for acute myocardial infarction.

Technology: A multicentre prospective model predicted new atrial fibrillation after emergency PCI for acute myocardial infarction.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
A multicentre prospective model predicted new atrial fibrillation after emergency PCI for acute myocardial infarction.
Limitation / still unknown
Full text reports the relevant cohort/measure, comparison or reference, and evaluation supporting this bounded claim.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13463156/ · https://pubmed.ncbi.nlm.nih.gov/42591778/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Development and validation of a novel interpretable machine learning model integrating immune-inflammatory indicators for intravenous immunoglobulin resistance in Kawasaki disease.

Source check: Source checked. Not independent scientific confirmation.

Finding: Interpretable models using immune-inflammatory indicators predicted IVIG resistance in Kawasaki disease and were evaluated in development/validation cohorts; the retrospective prediction result does not establish treatment benefit.

Technology: LightGBM, random forest, XGBoost, neural network, SVM and ElasticNet logistic regression models predict IVIG resistance in children with Kawasaki disease; SHAP explains feature contributions.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
LightGBM, random forest, XGBoost, neural network, SVM and ElasticNet logistic regression models predict IVIG resistance in children with Kawasaki disease; SHAP explains feature contributions.
Test and result
Among 1,584 patients, LightGBM achieved test-set AUC 0.832 (95% CI 0.766–0.898), sensitivity 0.860 and specificity 0.639; leading features included fever duration, NLR, IL-1β, albumin and AST.
Limitation / still unknown
Retrospective single-hospital data were randomly divided into training and test sets; external prospective performance is unknown.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.21037/tp-2025-1-907 · https://europepmc.org/article/MED/41982958 · https://europepmc.org/articles/PMC13071721 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC13071721/unicode · https://pubmed.ncbi.nlm.nih.gov/41982958/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.